RU95115489A - METHOD FOR DIAGNOSTIC OF COMPLICATIONS OF PREGNANCY AND FORECASTING OF BIRTH - Google Patents
METHOD FOR DIAGNOSTIC OF COMPLICATIONS OF PREGNANCY AND FORECASTING OF BIRTHInfo
- Publication number
- RU95115489A RU95115489A RU95115489/14A RU95115489A RU95115489A RU 95115489 A RU95115489 A RU 95115489A RU 95115489/14 A RU95115489/14 A RU 95115489/14A RU 95115489 A RU95115489 A RU 95115489A RU 95115489 A RU95115489 A RU 95115489A
- Authority
- RU
- Russia
- Prior art keywords
- pregnancy
- sbag
- tbg
- complications
- globulin
- Prior art date
Links
- 230000035935 pregnancy Effects 0.000 title claims 2
- 102000007502 Pregnancy-Specific beta 1-Glycoproteins Human genes 0.000 claims 4
- 108010085648 Pregnancy-Specific beta 1-Glycoproteins Proteins 0.000 claims 4
- 208000002787 Pregnancy Complications Diseases 0.000 claims 2
- 230000000984 immunochemical Effects 0.000 claims 2
- 229920001817 Agar Polymers 0.000 claims 1
- 102000008217 Pregnancy Proteins Human genes 0.000 claims 1
- 108010035746 Pregnancy Proteins Proteins 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 239000008272 agar Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000000951 immunodiffusion Effects 0.000 claims 1
- 230000004301 light adaptation Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000004448 titration Methods 0.000 claims 1
Claims (2)
КИА = (СБАГ + ТБГ) : ТБГ,
судят о наличии осложнения беременности с последующим прогнозированием состояния новорожденного.1. A method for diagnosing pregnancy complications and predicting the outcome of labor based on the determination of pregnancy proteins, characterized in that immunocompetent maternal blood serum proteins associated with pregnancy alpha 2- globulin (SBAG) and trophoblastic beta-globulin (TBG) are determined by the immunochemical method, and then according to the level of SBAG and TBH, as well as the magnitude of the coefficient reflecting the immunological adaptation of the mother and fetoplacental complex (CIA), determined by the formula
KIA = (SBAG + TBG): TBG,
judge the presence of pregnancy complications with subsequent prediction of the condition of the newborn.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95115489A RU2120636C1 (en) | 1995-09-04 | 1995-09-04 | Method for diagnosing pregnancy complications and predicting fetus and newborn state |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95115489A RU2120636C1 (en) | 1995-09-04 | 1995-09-04 | Method for diagnosing pregnancy complications and predicting fetus and newborn state |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95115489A true RU95115489A (en) | 1997-09-10 |
RU2120636C1 RU2120636C1 (en) | 1998-10-20 |
Family
ID=20171813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95115489A RU2120636C1 (en) | 1995-09-04 | 1995-09-04 | Method for diagnosing pregnancy complications and predicting fetus and newborn state |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2120636C1 (en) |
-
1995
- 1995-09-04 RU RU95115489A patent/RU2120636C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK107391A (en) | Isolation of fetal cells from maternal blood to enable diagnosis before birth | |
US5712103A (en) | Diagnostic assay for the prediction of preeclampsia | |
JPS58168961A (en) | Method of measuring procollagen-peptides and manufacture of anti-procollagen-peptide serum | |
Belanger et al. | Double-antibody enzyme immunoassay applied to human alpha 1-fetoprotein. | |
IE44204L (en) | Reagent for pregnancy testing | |
EP0230934A3 (en) | Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor. | |
EP0279705A3 (en) | Screening body fluids for superoxide dismutase (sod-1) for determining fetal trisomy 21 down syndrome, and antibodies, hybridomas and kits therefor | |
Bech et al. | Effect of maternal thyroid autoantibodies and post-partum thyroiditis on the fetus and neonate | |
RU95115489A (en) | METHOD FOR DIAGNOSTIC OF COMPLICATIONS OF PREGNANCY AND FORECASTING OF BIRTH | |
AU635243B2 (en) | Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody | |
Epstein et al. | Naturally-occurring macroglobulin antibody of foetal origin in the normal human newborn | |
JP2736058B2 (en) | Manufacturing method of immunoassay device | |
Alfthan et al. | Specificity and detection limit of ten pregnancy tests | |
US4786591A (en) | Process for determining the binding capacity of thyroxin-binding globulin | |
US5238813A (en) | Diagnostic method for nephritis | |
ATE180894T1 (en) | USE OF POLYCLONAL HUMAN ANTI-HTG AUTOANTIBODIES AS A REAGENT FOR CLINICAL DIAGNOSTICS OF THYROID AUTOIMMUNE DISEASES AND REAGENT SET FOR DETERMINATION OF ANTI-HTG AUTOANTIBODIES IN PATIENT SERA | |
Bersinger | Two-site enzyme immunoassay for pregnancy associated plasma protein A (PAPP-A) | |
EP0315447A3 (en) | Method of immunological measurement of human protein s and reagent and kit therefor | |
Boerrigter et al. | Direct measurement of in vitro antibody production using an enzyme-linked immunosorbent assay | |
KR870002453A (en) | Method for manufacturing single antibody against prosome protein and detection of symptoms related to prosome and diagnosis of disease using the method | |
EP0781998B1 (en) | Immunological determination method | |
Sterzik et al. | Beta-1-glycoprotein determination in normal and disturbed pregnancy | |
Gause et al. | Autoanti-thyroglobulin production in Obese chickens: Influence of age and sex as measured by ELISA | |
KR970000247A (en) | Diagnostic reagents and diagnostic kits for prenatal intrauterine infection and perinatal diagnosis | |
US5593898A (en) | Diagnostic method for the immunological determination of NCAM |